Home > Category > > Small Molecule Compound > Sitravatinib

Sitravatinib

Glpbio

Catalog No：GC19332-100mg CAS No.：1123837-84-2 MDLNo： Brand:Glpbio purity： 特性： Purpose:Sitravatinib is a novel small molecule inhibitor targeting multiple RTKs involved in driving sarcoma cell growth with IC50 of 3980 nmol/L.DMSO : ≥ 32 mg/mL (50.82 mM)

Share

Size	Availability	Price(USD)
There is no price information at the moment, you can send an inquiry,and we will reply to you as soon as possible.

Chemical safety data sheet(MSDS)

Download MSDS

Inquiry

Product Overview
Related documents
Related literature

Product Overview

Product Name	Sitravatinib
CAS	1123837-84-2
Formula	C₃₃H₂₉F₂N₅O₄S
MW	629.68
Storage condition	Store at -20°C

Related literature

Sorry, there is no relevant literature

Related

Isotachysterol 3

Isotachysterol 3

Isotachysterol 3

Isotachysterol 3

Isotachysterol 3

Isotachysterol 3

Isotachysterol 3

Isotachysterol 3

9-Hydroxycamptothecin

9-Hydroxycamptothecin

9-Hydroxycamptothecin

9-Hydroxycamptothecin

9-Hydroxycamptothecin

9-Hydroxycamptothecin

9-Hydroxycamptothecin

9-Hydroxycamptothecin

LCKLSL hydrochloride

LCKLSL hydrochloride

LCKLSL hydrochloride

LCKLSL hydrochloride

History

Sitravatinib

Resorcinol monoacetate (Acetylresorcinol)

Resorcinol monoacetate (Acetylresorcinol)

Fmoc-Ser(tBu)-Thr(Psi(Me,Me)pro)-OH

Fmoc-Ser(tBu)-Thr(Psi(Me,Me)pro)-OH

96 WELL BLACK/CLEAR BTM P-D-L

96 WELL BLACK/CLEAR BTM P-D-L

BVT 2733

Betamethasone-17-butyrate-21-propionate

Betamethasone-17-butyrate-21-propionate

Bimosiamose (TBC 1269)

Bimosiamose (TBC 1269)